Phase II randomized study of high-dose interferon alfa-2b (HDI) versus chemotherapy as adjuvant therapy in patients with resected mucosal melanoma.
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Bin Lian, Li Li Mao, Chuan Liang Cui, Zhi Hong Chi, Lu Si, Xi Nan Sheng, Si Ming Li, Bi Xia Tang, Jun Guo
Institution: Peking University Cancer Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2598293100
